Condition: HIV Infections · HCV · Drug Overdose · Sponsor: Johns Hopkins Bloomberg School of Public Health
A pilot injection-setting targeted peer-driven intervention to reduce HIV and hepatitis C virus transmission and overdose risk behaviors among people who inject drugs (PWID).
This description comes directly from the study's public registry record.
Carl Latkin, PhD · 410-955-3972 · carl.latkin@jhu.edu
Lauren Dayton, PhD · 4105025368 · ldayton2@jhu.edu
Always discuss trial participation with your own doctor first.
| Lighthouse Studies at Peer Point | Baltimore, Maryland, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05320835